Be a PRO & get up to 50% off on select brands. Explore Now

Buy Syngene International; target of Rs 700: Globe Capital Market

Globe Capital Market is bullish on Syngene International has recommended buy rating on the stock with a target price of Rs 700 in its research report dated May 02, 2019.

May 03, 2019 / 03:59 PM IST
  • bselive
  • nselive
Todays L/H

Globe Capital Market's report on Syngene International

Syngene International Limited (Syngene) is among the world’s leading Contract Research Organisations (CROs), providing integrated discovery and development services for novel molecules across multiple platforms, including small molecules, large molecules, antibody drug conjugates and oligonucleotides. It caters to global pharma companies as well as industry leaders in segments such as biotechnology, nutrition, animal health, consumer goods and specialty chemicals.


At the current price of Rs 605, the stock is trading at ttm P/E multiple of 36.6x. Hence, we recommend ‘BUY’ for the target price of Rs. 700 for 12 months perspective.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on are their own, and not that of the website or its management. advises users to check with certified experts before taking any investment decisions.

Broker Research
first published: May 3, 2019 03:59 pm

stay updated

Get Daily News on your Browser
Enjoying Moneycontrol?

How about a quick survey to help us improve our services?

Ok, sure

Maybe next time!